Searches for “cod liver oil pregnancy” often lead to a wider question: can omega-3 supplements help prevent preterm birth? The answer is not a clear yes for everyone. Reviews disagree on the overall effect, while a 2022 international statement says people with low omega-3 intake may benefit most. Supplements are not a substitute for antenatal care or any treatment your clinician has prescribed.
Cod Liver Oil Pregnancy: What The Trials Say
Omega-3s include DHA (docosahexaenoic acid) and EPA (eicosapentaenoic acid), found in marine oils, including fish and algae products. A systematic review by Sumit Kar, Min Wong, Ewelina Rogozinska and Shakila Thangaratinam, researchers affiliated with Queen Mary University of London and London’s Royal London Hospital, pooled nine trials involving 5,980 women. It concluded that omega-3 supplements reduced the risk of both early preterm birth (before 34 weeks) and preterm birth before 37 weeks. The review did not establish a consistent difference by dose, timing or risk status.
A 2016 updated systematic review led by Sydne Newberry reached a more cautious conclusion. It assessed randomized trials and observational studies, with its searches covering research through August 2015. The authors found low-strength evidence that DHA, EPA plus DHA, or DHA-enriched fish oil did not reduce preterm-birth risk, although DHA had a small positive effect on pregnancy length. That is not the same as proving supplements never help; it means the overall trial results available to that review did not establish a reliable reduction in risk.
The reviews’ different conclusions matter: the earlier positive result is not a guarantee, and the broader review’s cautious finding does not rule out benefit for particular groups. A 2022 statement from the International Society for the Study of Fatty Acids and Lipids (ISSFAL), drawing on a Cochrane review and later trials, argues that baseline omega-3 status helps explain why results vary.
Why Baseline Intake And Dose May Matter
ISSFAL says pregnant people with adequate omega-3 intake early in pregnancy should maintain it, while those with low intake may benefit more from supplementation. For people with low omega-3 levels, the statement describes about 1,000 mg (1 g) total DHA plus EPA daily as effective at reducing early-birth risk, preferably starting before 20 weeks. This is a position statement—not a universal prescription—and the trials behind it largely involved singleton pregnancies in upper-middle- or high-income countries. It cannot tell you that the same dose is right for you, especially if your usual diet or health circumstances differ.
Plant sources such as flaxseed provide ALA, not the long-chain DHA and EPA in fish or algae oils. Product labels also differ in how much DHA and EPA a serving contains. If you are comparing products, this guide to reading an omega-3 label for EPA and DHA can help you identify those amounts. A cod liver oil product should not be assumed to match a trial dose just because it is a marine oil.
Guidance Depends On Where You Live
The World Health Organization’s guidance page says current evidence is not enough to support routine marine-oil supplementation specifically to reduce preterm birth, though supplementation may increase pregnancy length. ISSFAL’s 2022 statement takes a more targeted approach, emphasizing adequate intake and greater potential benefit for people with low omega-3 status. These are not identical recommendations: one addresses routine supplementation, while the other highlights possible benefit in a lower-intake group.
Neither statement establishes a single current policy for the United States, United Kingdom, European Union and Australia. Local antenatal advice may differ, and an international professional statement is not the same as a national guideline. Ask your maternity care team what applies where you live and whether your dietary intake or supplement is relevant.
What Is Known About Safety?
In the updated systematic review, omega-3 supplementation did not produce serious adverse events; mild gastrointestinal symptoms were the main reported exception. That is reassuring, but it does not make every product or dose suitable for every pregnancy. The WHO page also notes that unrefined fish-oil preparations may raise contaminant concerns. Check the specific product and its DHA and EPA amounts with your clinician or pharmacist, particularly if you take other supplements or medicines.
Most importantly, do not stop or replace prescribed antenatal care with an omega-3 supplement. If you have concerns about preterm-birth risk, or are considering a higher-dose product, discuss them with your maternity clinician, who can consider your history and local guidance.



















